Results 61 to 70 of about 779,609 (165)
A photocontrolled RAFT strategy enables the alternating copolymerization of 1,3‐disubstituted bicyclo[1.1.0]butanes with electron‐deficient comonomers, affording well‐defined copolymers bearing strained cyclobutane backbones. A high degree of alternation, tunable molecular weights, and excellent end‐group fidelity are achieved through a CTA‐mediated ...
Xia Hu +4 more
wiley +2 more sources
Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar. Data from follow-up periods longer than 1 year are still scarce.
María Fernanda Guerra Veloz +9 more
doaj +1 more source
Aim Clozapine, used for treatment‐resistant schizophrenia, has a narrow therapeutic window and highly variable plasma pharmacokinetics (PK), necessitating careful monitoring. Direct measurement of unbound brain PK in humans is unethical. To develop a physiologically based pharmacokinetic–pharmacodynamic (PBPK‐PD) model to predict clozapine brain ...
Mengxu Zhang +3 more
wiley +1 more source
No difference in TNF-alfa neutralizing effect comparing IFX with IFX biosimilar CT-P13 (Inflectra).
No difference in TNF-alfa neutralizing effect comparing IFX with IFX biosimilar CT-P13 (Inflectra).
B. T. Pham (6069263) +6 more
core +1 more source
ABSTRACT Introduction Suicidal ideation and behaviors (SIB) are common among individuals at clinical high risk for psychosis (CHR‐P), but their relationship with the overall clinical profile remains unclear. This study aimed to identify sociodemographic/clinical factors associated with SIB in CHR‐P individuals and to examine whether subthreshold ...
Stefano Damiani +73 more
wiley +1 more source
Copyright modification of the article: "Effectiveness and safety of CT-P13 (infliximab biosimilar) in patients with inflammatory bowel disease in real-life settings at 6 months"
Guerra Veloz, María Fernanda +8 more
core +1 more source
Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati +6 more
wiley +1 more source
IntroductionTNF-α-neutralizing antibodies, such as infliximab (IFX) and adalimumab (ADA), are effective in the treatment of inflammatory bowel diseases (IBD), but they are expensive and become ineffective when patients develop anti-IFX or anti-ADA ...
D J Buurman +6 more
doaj +1 more source
Developing agency through experiences of misalignment: A path to becoming a physician
Abstract Introduction How medical students respond to the dissonance that can result from misalignments between personal values and the norms and values of the profession informs their evolving professional identities. But to what extent do medical students have agency to respond intentionally to these experiences?
Robert Sternszus +6 more
wiley +1 more source
Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study [PDF]
To assess the efficacy, tolerability, and safety of CT-P13 (Remsima(®)) in patients with Crohn's disease (CD) or ulcerative colitis (UC).This was a prospective observational study performed in a single center in Norway. Patients with CD (n = 46) or UC (n = 32) received CT-P13 (5 mg/kg) by intravenous infusion at weeks 0, 2, and 6.
Jørgen, Jahnsen +3 more
openaire +2 more sources

